BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 6, 2024
Product Development

Alzheimer’s roundup: Clinical progress and setbacks at CTAD

Readouts showcase promise of Roche’s brainshuttle; plus mixed results from Lilly, Lexeo and Anavex
BioCentury | Apr 2, 2024
Product Development

Vectorized biologics: are patients and payers ready to swap biologics for gene therapies?

Gene therapy vectors that deliver biologic drugs enter late-state clinical trials
BioCentury | Mar 3, 2022
Deals

March 2 Quick Takes: Sanofi adds mAb masking tech in Adagene deal

Plus NIH ends only active arm in ACTIV-2 and updates from Oculis, Ampio, Inovio, Epsilogen, Lexeo, BlueWillow-Medigen, Epigeneron
Items per page:
1 - 3 of 3